Bifogade filer
Prenumeration
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
The following members have been appointed to Surgical Sciences' Nomination Committee for the 2025 Annual General Meeting:
Åsa Hedin, appointed by Marknadspotential AB
Anna Sundberg, appointed by Handelsbanken Fonder
Erik Sprinchorn, appointed by TIN Fonder
Roland Bengtsson, Chairman of the Board
The appointments have been made in accordance with the instructions regarding principles for the appointment of the company’s Nomination Committee established at the Annual General Meeting of Surgical Science on May 16, 2024. The shareholders that have appointed the members of the Nomination Committee represented in aggregate just below 27 percent of all shares in the company as of August 31, 2024.
The Nomination Committee shall prepare and submit proposals to the Annual General Meeting regarding: (i) election of Chairman of the Meeting, (ii) election of board members, (iii) election of Chairman of the Board, (iv) resolution on board remuneration with the division between the chairman and other members of the board, (v) resolution on remuneration for the members of the Remuneration and Audit Committee, (vi) election of auditors, (vii) resolution on remuneration of auditors, and (viii) to the extent deemed necessary, resolution on amendments in current rules for the Nomination Committee.
The Annual General Meeting of Surgical Science Sweden AB (publ) will be held on Thursday, May 15, 2025 in Gothenburg. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so in due time before the 2025 Annual General Meeting so that the Nomination Committee has time to consider the proposal. Proposals may be sent to Surgical Science Sweden AB (publ), Att: Nomination Committee, Drakegatan 7A, 412 50 Gothenburg, Sweden.
Gothenburg, Sweden, October 22, 2024
Surgical Science Sweden AB (publ)
The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.